Fundraising Fox
CapyBio
2 known investors
Find your way into CapyBio
Sign up to see every warm intro you have to CapyBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CapyBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CapyBio provides tools to measure how closely cells match a target identity and to improve them, helping scientists and biopharma teams reduce failure in drug discovery, build stronger disease models, and advance cell-based therapies. The company applies cell biology and computational methods to cell identity for research, testing, and regenerative medicine.
Founders & leadership
GR
Guillermo RiveraInterim CEO, Co-Founder & CSOGuillermo Rivera holds a Ph.D. in Biology and has held positions as a Senior Scientist and Postdoctoral Associate at leading institutions, where he developed expertise in stem cell research, single-cell sequencing, and gene therapy, with published work in adipocyte differentiation and cell lineage tracing. He is Interim CEO, Co-Founder, and Chief Scientific Officer of CapyBio, which develops tools to measure and improve cell identity for drug discovery and cell-based therapeutic applications.
SM
Samantha MorrisCo-Founder
KJ
Kunal JindalCo-Founder & CTOHe has research expertise in single-cell and spatial genomics, stem cell biology, and machine learning, with a focus on developing tools for analyzing biological systems.
Investors · 2
Missouri Technology Corporationlisted by Missouri Technology CorporationSt. Louis
How we know: Missouri Technology Corporation's portfolio page · funding news · Not right? Tell us
Cultivation CapitalreportedSt. Louis · $100K – $3.5M
How we know: the VCSheet dataset · Not right? Tell us
Related companies · 5
BridgebioBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
AskBioAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.
Capio BiosciencesCapio Biosciences develops the CapioCyte platform, an ultra-sensitive technology for capturing and analyzing circulating tumor cells (CTCs) from whole blood. The oncology diagnostics tool is aimed at cancer research and potential future clinical use to support treatment decisions.
PipeBioPipeBio provides a bioinformatics platform for drug discovery that enables scientists and bioinformaticians to analyze genomic and assay data. The platform combines sequence data management, machine learning tools, and visualization capabilities to accelerate therapeutic development for academia, biotech companies, and pharmaceutical firms.
ARTBIOARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue. The company covers the design, manufacture, and distribution of its therapies and builds on radiation research from the University of Oslo and Norway's Radium Hospital.
Companies working in the same space as CapyBio.
Frequently asked questions
- What does CapyBio do?
- CapyBio provides tools to measure how closely cells match a target identity and to improve them, helping scientists and biopharma teams reduce failure in drug discovery, build stronger disease models, and advance cell-based therapies. The company applies cell biology and computational methods to cell identity for research, testing, and regenerative medicine.
- Who founded CapyBio?
- CapyBio was founded by Guillermo Rivera, Samantha Morris, Kunal Jindal.
- Who are CapyBio's investors?
- CapyBio's investors include Missouri Technology Corporation, Cultivation Capital.